FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| SKNV | 72934-2529 | 72934-2529-2 | Purazil | 161021 CALCIPOTRIENE 0.005% / NIACINAMIDE 4% | 4 g/100 g; .005 g/100 g | 2025-1 | valid | 2026-09-18 | |
| SKNV | 72934-1530 | 72934-1530-2 | Remyda | 171010 BRIMONIDINE TARTRATE 0.25% | .25 g/100 g | 2025-1 | valid | 2026-09-18 | |
| SKNV | 72934-1531 | 72934-1531-2 | Restimo | 171081 IVERMECTIN 1% / METRONIDAZOLE 1% | 1 g/100 g; 1 g/100 g | 2025-1 | valid | 2026-09-18 | |
| SKNV | 72934-1533 | 72934-1533-2 | Rositara | 171083 IVERMECTIN 1% / METRONIDAZOLE 1% / NIACINAMIDE 4% | 4 g/100 g; 1 g/100 g; 1 g/100 g | 2025-1 | valid | 2026-09-18 | |
| SKNV | 72934-1532 | 72934-1532-2 | Rovis | 171082 BRIMONIDINE TARTRATE 0.25% / IVERMECTIN 1% / METRONIDAZOLE 1% / NIACINAMIDE 4% | 4 g/100 g; 1 g/100 g; 1 g/100 g; .25 g/100 g | 2025-1 | valid | 2026-09-18 | |
| SKNV | 72934-2547 | 72934-2547-2 | Rumilo | 351014 AZELAIC ACID 15% / NIACINAMIDE 4% | 4 g/100 g; 15 g/100 g | 2025-1 | valid | 2026-09-18 | |
| SKNV | 72934-1545 | 72934-1545-2 | Sirvana | 271006 NIACINAMIDE 5% / TRETINOIN 0.025% | 5 g/100 g; .025 g/100 g | 2025-1 | valid | 2026-09-18 | |
| SKNV | 72934-2546 | 72934-2546-2 | Sorixia | 271036 NIACINAMIDE 4% / TRETINOIN 0.05% | 4 g/100 g; .05 g/100 g | 2025-1 | valid | 2026-09-18 | |
| SKNV | 72934-1551 | 72934-1551-2 | Teliora | 351024 PENTOXIFYLLINE 0.5% / TRIAMCINOLONE ACETONIDE 0.1% | .1 g/100 g; .5 g/100 g | 2025-1 | valid | 2026-09-18 | |
| SKNV | 72934-2540 | 72934-2540-2 | Venven | 211010 TACROLIMUS 0.1% IN PSEUDOCATALASE | .1 g/100 g | 2025-1 | valid | 2026-09-18 | |
| SKNV | 72934-9542 | 72934-9542-1 | Walinox | 221025 CANTHARIDIN 1% / PODOPHYLLUM RESIN 5% / SALICYLIC ACID 30% | 1 g/100 mL; 5 g/100 mL; 30 g/100 mL | 2025-1 | valid | 2026-09-18 | |
| SKNV | 72934-1543 | 72934-1543-2 | Wayzen | 221034 LIDOCAINE 5% / SALICYLIC ACID 40% | 40 g/100 g; 5 g/100 g | 2025-1 | valid | 2026-09-18 | |
| SKNV | 72934-1541 | 72934-1541-2 | Weleris | 221012 IBUPROFEN 2% / SALICYLIC ACID 17% | 2 g/100 g; 17 g/100 g | 2025-1 | valid | 2026-09-18 | |
| SKNV | 72934-1544 | 72934-1544-6 | Xirun | 241019 LACTIC ACID 10% / UREA 40% | 40 g/100 g; 10 g/100 g | 2025-1 | valid | 2026-09-18 | |
| SSM Health Businesses dba Park Avenue Compounding | 119151370 | 83863-0104 | 83863-0104-1 | Phenylephrine Hydrochloride | .1 mg/1 mL | 2025-1 | valid | 2026-10-31 | |
| SSM Health Businesses dba Park Avenue Compounding | 119151370 | 83863-6429 | 83863-6429-1 | Potassium Chloride | 2 meq/1 mL | 2025-1 | valid | 2026-10-31 | |
| SSM Health Businesses dba Park Avenue Compounding | 119151370 | 83863-0651 | 83863-0651-1 | Rocuronium Bromide | 10 mg/1 mL | 2025-1 | valid | 2026-10-31 | |
| SSM Health Businesses dba Park Avenue Compounding | 119151370 | 83863-4272 | 83863-4272-1 | Ropivacaine Hydrochloride; Fentanyl Citrate | 2 mg/1 mL; .002 mg/1 mL | 2025-1 | valid | 2026-10-31 | |
| SSM Health Businesses dba Park Avenue Compounding | 119151370 | 83863-7536 | 83863-7536-1 | Succinylcholine Chloride | 20 mg/1 mL | 2025-1 | valid | 2026-10-31 | |
| SSM Health Businesses dba Park Avenue Compounding | 119151370 | 83863-6015 | 83863-6015-1 | Diltiazem Hydrochloride | 1 mg/1 mL | 2025-1 | valid | 2026-10-31 | |
| SSM Health Businesses dba Park Avenue Compounding | 119151370 | 83863-9010 | 83863-9010-2 | Fentanyl Citrate | .01 mg/1 mL | 2025-1 | valid | 2026-10-31 | |
| SSM Health Businesses dba Park Avenue Compounding | 119151370 | 83863-6030 | 83863-6030-1 | Fentanyl Citrate | .05 mg/1 mL | 2025-1 | valid | 2026-10-31 | |
| SSM Health Businesses dba Park Avenue Compounding | 119151370 | 83863-0329 | 83863-0329-1 | Neostigmine Methylsulfate | 1 mg/1 mL | 2025-1 | valid | 2026-10-31 | |
| SSM Health Businesses dba Park Avenue Compounding | 119151370 | 83863-0903 | 83863-0903-1 | Oxytocin | .06 U/1 mL | 2025-1 | valid | 2026-10-31 | |
| STAQ Pharma Inc | 030633271 | 73177-115 | 73177-115-03 | Phenylephrine Hydrochloride | 80 ug/1 mL | 2025-1 | valid | 2026-10-31 | |
| STAQ Pharma Inc | 030633271 | 73177-115 | 73177-115-25 | Phenylephrine Hydrochloride | 80 ug/1 mL | 2025-1 | valid | 2026-10-31 | |
| STAQ Pharma Inc | 030633271 | 73177-166 | 73177-166-25 | Phenylephrine Hydrochloride | 160 ug/1 mL | 2025-1 | valid | 2026-10-31 | |
| STAQ Pharma Inc | 030633271 | 73177-112 | 73177-112-03 | Phenylephrine Hydrochloride | 40 ug/1 mL | 2025-1 | valid | 2026-10-31 | |
| STAQ Pharma Inc | 030633271 | 73177-108 | 73177-108-03 | Phenylephrine Hydrochloride | 100 ug/1 mL | 2025-1 | valid | 2026-10-31 | |
| STAQ Pharma Inc | 030633271 | 73177-127 | 73177-127-05 | Potassium Chloride | 2 meq/1 mL | 2025-1 | valid | 2026-10-31 | |
| STAQ Pharma Inc | 030633271 | 73177-159 | 73177-159-03 | Rocuronium Bromide | 10 mg/1 mL | 2025-1 | valid | 2026-10-31 | |
| STAQ Pharma Inc | 030633271 | 73177-159 | 73177-159-02 | Rocuronium Bromide | 10 mg/1 mL | 2025-1 | valid | 2026-10-31 | |
| STAQ Pharma Inc | 030633271 | 73177-109 | 73177-109-26 | Ropivacaine Hydrochloride | 2 mg/1 mL | 2025-1 | valid | 2026-10-31 | |
| STAQ Pharma Inc | 030633271 | 73177-109 | 73177-109-13 | Ropivacaine Hydrochloride | 2 mg/1 mL | 2025-1 | valid | 2026-10-31 | |
| STAQ Pharma Inc | 030633271 | 73177-109 | 73177-109-20 | Ropivacaine Hydrochloride | 2 mg/1 mL | 2025-1 | valid | 2026-10-31 | |
| STAQ Pharma Inc | 030633271 | 73177-109 | 73177-109-14 | Ropivacaine Hydrochloride | 2 mg/1 mL | 2025-1 | valid | 2026-10-31 | |
| STAQ Pharma Inc | 030633271 | 73177-169 | 73177-169-26 | Sodium Chloride | 9 mg/1 mL | 2025-1 | valid | 2026-10-31 | |
| STAQ Pharma Inc | 030633271 | 73177-116 | 73177-116-03 | Succinylcholine Chloride | 20 mg/1 mL | 2025-1 | valid | 2026-10-31 | |
| STAQ Pharma Inc | 030633271 | 73177-116 | 73177-116-02 | Succinylcholine Chloride | 20 mg/1 mL | 2025-1 | valid | 2026-10-31 | |
| STAQ Pharma Inc | 030633271 | 73177-114 | 73177-114-15 | Desmopressin Acetate | 1.5 mg/1 mL | 2025-1 | valid | 2026-10-31 | |
| STAQ Pharma Inc | 030633271 | 73177-123 | 73177-123-02 | Dexmedetomidine Hydrochloride | 4 ug/1 mL | 2025-1 | valid | 2026-10-31 | |
| STAQ Pharma Inc | 030633271 | 73177-164 | 73177-164-03 | Epinephrine Bitartrate | 10 ug/1 mL | 2025-1 | valid | 2026-10-31 | |
| STAQ Pharma Inc | 030633271 | 73177-121 | 73177-121-19 | Epinephrine Bitartrate; Tetracaine Hydrochloride; Lidocaine Hydrochloride | .905 mg/1 mL; 5 mg/1 mL; 40 mg/1 mL | 2025-1 | valid | 2026-10-31 | |
| STAQ Pharma Inc | 030633271 | 73177-163 | 73177-163-33 | Albuterol Sulfate | 5 mg/1 mL | 2025-1 | valid | 2026-10-31 | |
| STAQ Pharma Inc | 030633271 | 73177-163 | 73177-163-32 | Albuterol Sulfate | 5 mg/1 mL | 2025-1 | valid | 2026-10-31 | |
| STAQ Pharma Inc | 030633271 | 73177-102 | 73177-102-25 | Fentanyl Citrate | 10 ug/1 mL | 2025-1 | valid | 2026-10-31 | |
| STAQ Pharma Inc | 030633271 | 73177-102 | 73177-102-01 | Fentanyl Citrate | 10 ug/1 mL | 2025-1 | valid | 2026-10-31 | |
| STAQ Pharma Inc | 030633271 | 73177-103 | 73177-103-16 | Fentanyl Citrate | 50 ug/1 mL | 2025-1 | valid | 2026-10-31 | |
| STAQ Pharma Inc | 030633271 | 73177-103 | 73177-103-04 | Fentanyl Citrate | 50 ug/1 mL | 2025-1 | valid | 2026-10-31 | |
| STAQ Pharma Inc | 030633271 | 73177-103 | 73177-103-05 | Fentanyl Citrate | 50 ug/1 mL | 2025-1 | valid | 2026-10-31 |